. 2023 Jan 3;13:89. doi: 10.1038/s41598-022-27269-6

Table 2.

Hematological variables.

Variables	Reference values	Without MetS n = 37		With MetS n = 59		p-value
Variables	Reference values	Mean ± SD	Med (iqr 25%-75%)	Mean ± SD	Med (iqr 25%-75%)	p-value
Leukocytes [10³/µL]	5.0–11.6	5.3 ± 1.1	5.2 (4.7–5.9)	5.9 ± 1.5	5.7 (4.9–6.6)	0.086
Lymphocytes [10³/µL]	1.3–4.0	1.8 ± 0.5	1.8 (1.4–2.0)	1.9 ± 0.6	1.8 (1.4–2.3)	0.244
Granulocytes [10³/µL]	2.4–7.6	3.2 ± 0.9	3.3 (2.6–3.6)	3.7 ± 1.2	3.5 (2.7–4.3)	0.059
LYM%	19.1–48.5	33.6 ± 7.3	34.8 (27.1–39.5)	32.5 ± 6.9	32.1 (27.8–27.7)	0.436
GRA%	43.6–73.4	60.3 ± 7.7	61.0 (54.6–66.3)	61.9 ± 6.7	62.5 (56.2–66.3)	0.292
RBC [10³/µL]	F 4.0–5.5	4.3 ± 0.3	4.4 (4.1–4.5)	4.6 ± 0.3	4.6 (4.4–4.8)	< 0.001
RBC [10³/µL]	M 4.5–6.6	4.3 ± 0.3	4.4 (4.1–4.5)	4.6 ± 0.3	4.6 (4.4–4.8)	< 0.001
HB [g/dL]	F 12.5–16.0	13.5 ± 1.0	13.5 (13.0–13.9)	14.2 ± 1.0	14.2 (13.7–14.6)	0.004
HB [g/dL]	M 13.5–18.0	13.5 ± 1.0	13.5 (13.0–13.9)	14.2 ± 1.0	14.2 (13.7–14.6)	0.004
HCT [%]	F 37–47	36.2 ± 2.8	36.1 (35.0–37.7)	38.3 ± 2.7	38.3 (36.6–39.9)	< 0.001
HCT [%]	M 40.0–51.0	36.2 ± 2.8	36.1 (35.0–37.7)	38.3 ± 2.7	38.3 (36.6–39.9)	< 0.001
MCV [fL]	F 80–95	83.7 ± 4.9	83.0 (81.0–86.0)	83.3 ± 3.1	83.0 (81.0–86.0)	0.662
MCV [fL]	M 80–97	83.7 ± 4.9	83.0 (81.0–86.0)	83.3 ± 3.1	83.0 (81.0–86.0)	0.662
MCH [pg]	F 27.0–32.0	31.3 ± 2.0	31.1 (30.2–32.0)	30.9 ± 1.3	30.9 (30.0–31.5)	0.132
MCH [pg]	M 26.0–32.0	31.3 ± 2.0	31.1 (30.2–32.0)	30.9 ± 1.3	30.9 (30.0–31.5)	0.132
MCHC [g/dL]	F 32.0–36.0	37.4 ± 0.7	37.5 (36.7–38.0)	37.0 ± 0.7	37.0 (36.60–37.6)	0.014
MCHC [g/dL]	M 31.0–36.0	37.4 ± 0.7	37.5 (36.7–38.0)	37.0 ± 0.7	37.0 (36.60–37.6)	0.014
PLT [10³/µL]	150–400	243.9 ± 53.5	240.0 (214.0–288.0)	239.7 ± 52.8	237.0 (217.8–268.0)	0.711

LYM lymphocytes, GRA granulocytes, RBC red blood cells, HB hemoglobin, HCT hematocrit, MCV mean corpuscular volume, MCH mean cells hemoglobin, MCHC mean corpuscular/hemoglobin concentration, PLT platelets, F female, M male, SD standard deviation, Med median, IGR interquartile.